Drug recall · March 9, 2016
Capecitabine tablets USP 500 mg recall
Why: Failed Dissolution Specifications: low test results at the 18 month time-point
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by: Teva Czech Industries sro, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7474-89
- Lots / codes
Lot # 3A404012V, Exp. 4/2016
- Quantity
- 1,895 bottles
- Company
- Teva North America, Horsham, PA
- Distribution
- Nationwide
- Initiated
- December 21, 2015 · Voluntary: Firm initiated
- Classified
- March 1, 2016
- Reported
- March 9, 2016
- Ended
- January 13, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Capecitabine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.